Neuroblastoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • Sarcoma
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2022-04-07
    Apr 7, 2022
    N
    Completed
    • Solid Tumors
    • +4 more
    • Recombinant human interleukin-15 (rhIL-15)
    • NK Cell Infusion
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2022-04-07
    Apr 7, 2022
    E
    Recruiting
    • Neuroblastoma
    • LY3295668 Erbumine
    • +2 more
    • Los Angeles, California
    • +35 more
    2022-04-06
    Apr 6, 2022
    N
    Recruiting
    • Endocrine Tumors
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2022-04-07
      Apr 7, 2022
      P
      Recruiting
      • Neuroblastoma
      • Philadelphia, Pennsylvania
      • +2 more
      2022-04-05
      Apr 5, 2022
      M
      Active, not recruiting
      • Ewing Sarcoma
      • +4 more
      • Allogeneic HCT
      • Donor NK Cell Infusion
      • Milwaukee, Wisconsin
      • +1 more
      2022-04-05
      Apr 5, 2022
      B
      Recruiting
      • Neuroblastoma
      • GINAKIT Cells
      • +2 more
      • Houston, Texas
        Texas Children's Hospital
      2022-03-29
      Mar 29, 2022
      S
      Not yet recruiting
      • Neuroblastoma
      • Anti Thymocyte Globulin
      • +10 more
      • Guangzhou, Guangdong, China
        Sun Yat-sen Memorial Hospital, Sun Yat-sen University
      2022-04-01
      Apr 1, 2022
      I
      Recruiting
      • Neuroblastoma
      • Boston, Massachusetts
      • +3 more
      2022-03-29
      Mar 29, 2022
      S
      Terminated
      • Recurrent Neuroblastoma
      • Neuroblastoma
      • Fenretinide/LXS Oral Powder
      • +2 more
      • Chicago, Illinois
      • +3 more
      2022-03-17
      Mar 17, 2022
      C
      Recruiting
      • Osteosarcoma
      • +9 more
      • Cryoablation Therapy
      • +2 more
      • Washington, District of Columbia
        Children's National Hospital
      2022-03-21
      Mar 21, 2022
      S
      Recruiting
      • Recurrent or Refractory Solid Tumors
      • +4 more
      • MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide
      • Cincinnati, Ohio
      • +5 more
      2022-03-17
      Mar 17, 2022
      C
      Recruiting
      • Ganglioneuroblastoma
      • +3 more
      • Birmingham, Alabama
      • +218 more
      2022-03-25
      Mar 25, 2022
      B
      Active, not recruiting
      • Neuroblastoma
      • Neuroblastoma Vaccine (unmodified SKNLP, with gene-modified SJNB-JF-IL2 and SJNB-JF-LTN neuroblastoma cells
      • Cytoxan
      • Houston, Texas
        Texas Children's Hospital
      2022-03-25
      Mar 25, 2022
      M
      Recruiting
      • Neuroblastoma
      • β-glucan
      • +2 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      2022-03-11
      Mar 11, 2022
      B
      Recruiting
      • Neuroblastoma
      • +5 more
      • GD2-CART01
      • Roma, Italy
        Ospedale Pediatrico Bambino Gesù
      2022-03-09
      Mar 9, 2022
      S
      No longer available
      • Recurrent Neuroblastoma
      • Neuroblastoma
      • Oklahoma City, Oklahoma
      • +2 more
      2022-03-17
      Mar 17, 2022
      G
      No longer available
      • Neuroblastoma
      • +5 more
      • eflornithine HCl
      • Charlotte, North Carolina
        Levine Children's Hospital
      2022-03-03
      Mar 3, 2022
      G
      Recruiting
      • Neuroblastoma
      • Diffuse Intrinsic Pontine Glioma
      • Tumor-specific ex vivo expanded autologous lymphocyte transfer (TTRNA-xALT)
      • Gainesville, Florida
      • +1 more
      2022-03-03
      Mar 3, 2022
      N
      Completed
      • Sarcoma
      • +3 more
      • Anti-GD2-CAR engineered T cells
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2022-03-15
      Mar 15, 2022
      M
      Recruiting
      • Neuroblastoma
      • Pheochromocytoma
      • iobenguane I 131
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      2022-02-28
      Feb 28, 2022
      U
      Recruiting
      • Neuroblastoma
      • +2 more
        • Mannheim, Baden-Württemberg, Germany
        • +1 more
        2022-02-20
        Feb 20, 2022